Patent ID: 11890275
Assignee: CELGENE QUANTICEL RESEARCH, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 1:
2. A compound having the structure of Formula I:, wherein a compound of Formula I includes a pharmaceutically acceptable salt thereof, and
wherein
X6 is CR7, wherein R7 is hydrogen, or alkyl;
R2 is CH3;
R5 is optionally substituted alkyl halogen
R6 is hydrogen, halogen, alkyl, or —OR22;
RA is, wherein X is a bond, CH2, CHR, or CRR′; wherein
R and R′ are independently halogen, halide, alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, —SO2R21, or —N(R22)SO2R21; wherein
each R21 is independently selected from alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl;
each R22 is independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl; and

R1 is hydrogen or optionally substituted alkyl, aryl, aralkyl, alkoxy, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, or heteroarylalkyl.